Ultragenyx Pharmaceutical Inc. buy Royal Bank of Canada
Start price
22.04.24
/
50%
€41.20
Target price
22.04.25
€72.35
Performance (%)
19.90%
Price
27.09.24
€48.40
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 19.90%. This prediction currently runs until 22.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | -7.810% | -7.810% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $77.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.00
26.09.24
26.09.24
€69.10
26.09.25
26.09.25
-1.22%
27.09.24
27.09.24